STAT+: Silence Therapeutics aims at Takeda with new data in rare blood cancer
STAT News · LC · trust 55/100
A rare blood cancer drug from Silence Therapeutics showed strong results in a trial, potentially setting it up to compete with a Takeda medicine.
Read the original at STAT News →
Open in TruthVane →